Find policies, billing codes, payers, states, and providers
CPT 96417: Add-On Intravenous Chemotherapy Infusion for Different Agent
CPT code 96417 designates an add-on intravenous chemotherapy infusion when a different anticancer drug is administered following a primary infusion. It matters nationally because it affects how multi-agent chemotherapy sessions are billed and how payment is apportioned across sequential infusions in outpatient oncology care. Correct use of the code supports accurate reporting of resources and helps distinguish separate drug administrations during a single encounter.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find a concise overview of the clinical context for using 96417, how it relates to initial and additional infusion codes, and the typical sites where the service is provided. The publication summarizes payer coverage considerations and common modifiers used with infusion services, and identifies associated clinical taxonomies and frequently billed ICD-10 diagnoses to clarify typical coding scenarios.
This brief gives clinicians, coders, and revenue cycle professionals a focused reference on when 96417 is applicable, how it sits alongside related infusion codes, and what to expect from major national payers in terms of coverage and coding practice.
Customize your policy alerts
Sign up for cpt 96417 policy alerts
Get alerted when payer policies referencing 96417 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 96417 is an add-on chemotherapy administration code used when a provider continues intravenous infusion to administer a different chemotherapy drug following a primary dose. The code captures continued administration of a separate cytotoxic or biologic agent using an infusion technique after the initial chemotherapy infusion has been given.
Service type: Intravenous chemotherapy infusion (add-on)
Typical site of service: Outpatient infusion center or hospital outpatient department
National Reimbursement Benchmarks
National averages show a clear gap between Medicare and commercial BUCA rates for CPT 96417: Medicare’s mean is $69.3 versus BUCA’s mean of $165.2, indicating BUCA averages about $95.9 higher per service than Medicare. That spread highlights material payment differences between a federal payer and an aggregated commercial benchmark, with Medicare centered near its median of $68 while BUCA sits closer to its $145 median.
Dispersion across payers varies: compute P75–P25 ranges and compare relative tightness. Blue Cross Blue Shield’s range is $95 (from $151 to $246), Aetna’s is $67 (from $66.3 to $133.2), Cigna’s is $69 (from $71 to $140), UnitedHealth Group’s is $57.5 (from $69.7 to $127.5), and BUCA’s is $82 (from $115.9 to $198.1). UnitedHealth Group is the tightest band at $57.5 and Blue Cross Blue Shield the widest at $95, with BUCA and Aetna/Cigna in between.